EDWARDS LIFESCIENCES CORPORATION Edwards Lifesciences Corporation Share Price
Equities
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 86.43 USD | -1.80% |
|
+0.57% | +13.35% |
| 04-26 | Evercore ISI Adjusts Price Target on Edwards Lifesciences to $89 From $92 | MT |
| 04-26 | Stifel Adjusts Price Target on Edwards Lifesciences to $85 From $83 | MT |
| Sales 2024 * | 6.56B 525B | Sales 2025 * | 7.19B 575B | Capitalization | 52.02B 4,165B |
|---|---|---|---|---|---|
| Net income 2024 * | 1.61B 129B | Net income 2025 * | 1.83B 147B | EV / Sales 2024 * | 7.67 x |
| Net cash position 2024 * | 1.7B 136B | Net cash position 2025 * | 2.89B 231B | EV / Sales 2025 * | 6.83 x |
| P/E ratio 2024 * |
32.3
x | P/E ratio 2025 * |
28.5
x | Employees | 19,800 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.59% |
More Fundamentals
* Assessed data
More news
Latest transcript on Edwards Lifesciences Corporation
More recommendations
More press releases
More news
| 1 day | -1.80% | ||
| 1 week | +0.57% | ||
| Current month | -9.55% | ||
| 1 month | -7.48% | ||
| 3 months | +18.01% | ||
| 6 months | +37.67% | ||
| Current year | +13.35% |
1 week
84.71
89.17
1 month
84.7196.12
Current year
71.6796.12
1 year
60.5796.12
3 years
60.57131.73
5 years
51.51131.73
10 years
13.02131.73
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 31/12/14 | |
| Chairman | 71 | 31/12/99 | |
Scott Ullem
DFI | Director of Finance/CFO | 57 | 31/12/13 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Leslie Heisz
BRD | Director/Board Member | 63 | 04/07/16 |
| Director/Board Member | 67 | 12/11/14 | |
Steven Loranger
BRD | Director/Board Member | 72 | 15/03/16 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.46% | 44 M€ | +0.64% | - | |
| 2.34% | 18 M€ | +3.79% | - | |
| 2.13% | 6 M€ | 0.00% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 86.43 | -1.80% | 4,979,943 |
| 25/04/24 | 88.01 | -0.68% | 4,295,297 |
| 24/04/24 | 88.61 | +0.98% | 3,234,988 |
| 23/04/24 | 87.75 | +0.91% | 2,663,641 |
| 22/04/24 | 86.96 | +1.19% | 2,408,082 |
Delayed Quote Nyse, April 26, 2024 at 09:00 pm
More quotes
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Calendar
07/05/2024
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
32
Last Close Price
86.43
USD
Average target price
94.66
USD
Spread / Average Target
+9.52%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +13.35% | 52.98B | |
| +8.07% | 218B | |
| +6.59% | 182B | |
| +11.26% | 132B | |
| +26.57% | 108B | |
| -0.62% | 47.59B | |
| -0.93% | 39.96B | |
| +11.54% | 39.22B | |
| +26.76% | 26.94B | |
| -12.18% | 19.28B |
- Stock Market
- Equities
- EW Stock
